References
- Indonesia S. Pertumbuhan Ekonomi Indonesia Triwulan II-2020; 2020. (17/02/Th. XXIV):1–12. [accessed 2021 May 5]. https://www.bps.go.id/pressrelease/2020/02/05/1755/ekonomi-indonesia-2019-tumbuh-5-02-persen.html
- Indonesia S. STATISTIK Pertumbuhan Ekonomi Indonesia Triwulan I-2020; 2020. [accessed 2021 May 5]. https://www.bps.go.id/pressrelease/2020/02/05/1755/ekonomi-indonesia-2019-tumbuh-5-02-persen.html.
- Kochhar S, Rath B, Seeber LD, Rundblad G, Khamesipour A, Ali M, Initiative VVS. Introducing new vaccines in developing countries. Expert Rev Vaccines. 2013;12(12):1465–78. doi:10.1586/14760584.2013.855612.
- Michelsen SW, Soborg B, Koch A, Carstensen L, Hoff ST, Agger EM, Lillebaek T, Sorensen HCF, Wohlfahrt J, Melbye M. The effectiveness of BCG vaccination in preventing Mycobacterium tuberculosis infection and disease in Greenland. Thorax. 2014;69(9):851–56. doi:10.1136/thoraxjnl-2014-205688.
- Purssell E. Reviewing the importance of the cold chain in the distribution of vaccines. Br J Community Nurs. 2015;20(10):481–86. doi:10.12968/bjcn.2015.20.10.481.
- Smith J, Lipsitch M, Almond JW. Vaccine production, distribution, access, and uptake. Lancet. 2011;378(9789):428–38. doi:10.1016/S0140-6736(11)60478-9.
- Wojda TR, Valenza PL, Cornejo K, McGinley T, Galwankar SC, Kelkar D, Sharpe RP, Papadimos TJ, Stawicki SP. The Ebola outbreak of 2014-2015: from coordinated multilateral action to effective disease containment, vaccine development, and beyond. J Glob Infect Dis. 2015;7(4):127. doi:10.4103/0974-777X.170495.
- Speiser DE, Bachmann MF. COVID-19: mechanisms of vaccination and immunity. Vaccines. 2020;8(3):404. doi:10.3390/vaccines8030404.
- AstraZeneca. COVID-19 vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of phase III trials; 2021. [accessed 2021 Aug 10]. https://www.astrazeneca.com/media-centre/press-releases/2021/covid-19-vaccine-astrazeneca-confirms-protection-against-severe-disease-hospitalisation-and-death-in-the-primary-analysis-of-phase-iii-trials.html.
- Olliaro P, Torreele E, Vaillant M. COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room. Lancet Micro. 2021;2:e279–e280. doi:10.1016/S2666-5247(21)00069-0.
- Pfizer. Pfizer and biontech conclude phase 3 study of COVID-19 vaccine candidate, meeting all primary efficacy endpoints; 2020. [accessed 2021 May 5]. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine.
- BBC. Covid vaccines - “spectacular” impact on serious illness; 2021. [accessed 2021 May 5]. https://www.bbc.com/news/health-56153600.
- US News. Single dose of coronavirus vaccines reduces hospitalization in seniors, U.K. study finds; 2021. [accessed 2021 Aug 8]. https://www.usnews.com/news/health-news/articles/2021-03-02/single-dose-of-coronavirus-vaccines-reduces-hospitalization-in-seniors-uk-study-finds#:~:text=Justonedoseofthe,peopleover80yearsold.
- MarketWatch. Single dose of AstraZeneca or Pfizer COVID-19 vaccine cuts hospitalization risk by more than 80%, study shows; 2021. [accessed 2021 Aug 8]. https://www.marketwatch.com/story/single-dose-of-astrazeneca-or-pfizer-covid-19-vaccine-cuts-hospitalization-risk-by-up-to-80-study-shows-11614688951.
- Moghadas SM, Vilches TN, Zhang K, Wells CR, Shoukat A, Singer BH, Meyers LA, Neuzil KM, Langley JM, Fitzpatrick MC. The impact of vaccination on COVID-19 outbreaks in the United States. medRxiv. 2020.
- BBC. Covid: Biden promises vaccines for all US adults by end of May; 2021. [accessed 2021 May 5]. https://www.bbc.com/news/world-us-canada-56262687.
- Koff WC, Schenkelberg T, Williams T, Baric RS, McDermott A, Cameron CM, Cameron MJ, Friemann MB, Neumann G, Kawaoka Y. Development and deployment of COVID-19 vaccines for those most vulnerable. Sci Transl Med. 2021;13:579. doi:10.1126/scitranslmed.abd1525.
- Cutler GJ. Vaccines and vaccination. In: Commercial chicken meat and egg production. Springer; 2002. p. 451–61.
- Hessel L, Group EVM (EVM) IW. Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges. Influenza Other Respi Viruses. 2009;3(4):165–70. doi:10.1111/j.1750-2659.2009.00085.x.
- Huang H-C, Singh B, Morton DP, Johnson GP, Clements B, Meyers LA. Equalizing access to pandemic influenza vaccines through optimal allocation to public health distribution points. PloS One. 2017;12(8):e0182720. doi:10.1371/journal.pone.0182720.
- Gauri V, Khaleghian P. Immunization in developing countries: its political and organizational determinants. The World Bank; 2002.
- Sankaranarayanan R. HPV vaccination: the promise & problems. Indian J Med Res. 2009;130:322–27.
- Sherris J, Friedman A, Wittet S, Davies P, Steben M, Saraiya M. Education, training, and communication for HPV vaccines. Vaccine. 2006;24:S210–S218. doi:10.1016/j.vaccine.2006.05.124.
- Streefland PH. Introduction of a HIV vaccine in developing countries: social and cultural dimensions. Vaccine. 2003;21(13–14):1304–09. doi:10.1016/S0264-410X(02)00685-0.
- The Strait Times. Pandemic could end in 7 years at current pace of vaccination; 2021 Feb 6. [accessed 2021 May 5]. https://www.straitstimes.com/world/pandemic-could-end-in-7-years-at-current-pace-of-vaccination
- Zainudin E. Bloomberg says > 10 years, but how many years is it actually? Nightingale; 2021. [accessed 2021 May 5]. https://medium.com/nightingale/bloomberg-says-10-years-but-how-many-years-is-it-actually-164c3c7c2732.
- Bloomberg. Covid-19 tracker; 2021. [accessed 2021 May 5]. https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/.
- Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(2):181–92. doi:10.1016/S1473-3099(20)30843-4.
- voi. Clinical trials of COVID-19 vaccine in Indonesia enter the monitoring period; 2020. [accessed 2021 Aug 8]. https://voi.id/en/news/19637/clinical-trials-of-covid-19-vaccine-in-indonesia-enter-the-monitoring-period.
- Antara. 110 Volunteers of Covid-19 vaccine trials in Bandung healthy: health office. Medcom.id; 2020. [accessed 2021 Aug 8]. https://www.medcom.id/english/national/5b2XO8aK-110-volunteers-of-covid-19-vaccine-trials-in-bandung-healthy-health-office.
- Biofarma. The Covid-19 vaccine can be used in Indonesia; 2021. [accessed 2021 Aug 8]. https://www.biofarma.co.id/en/latest-news/detail/the-covid19-vaccine-can-be-used-in-indonesia.
- Salma. The Sinovac vaccine, which showed an efficacy of 65.3 percent, is declared safe; 2021. [accessed 2021 Aug 8]. https://www.ugm.ac.id/en/news/20611-ugm-expert-having-an-efficacy-rate-of-65-3-percent-sinovac-vaccine-remains-safe.
- Ciabattini A, Nardini C, Santoro F, Garagnani P, Franceschi C, Medaglini D. Vaccination in the elderly: the challenge of immune changes with aging. In: Seminars in immunology. Vol. 40. Elsevier; 2018. p. 83–94.
- Heydari A, Sharifi M, Bagheri Moghaddam A. Challenges and barriers to providing care to older adult patients in the intensive care unit: a qualitative research. Open Access Maced J Med Sci. 2019 Nov 15;7(21):3682–90. doi:10.3889/oamjms.2019.846.
- Indonesia M of HA. Lembaga Kemasyarakatan Desa Dan Lembaga Adat Desa. Indonesia; 2018.
- Indonesia MM. Rukun Tetangga Dan Rukun Warga. Indonesia; 2012.
- OECD. Coronavirus (COVID-19) vaccines for developing countries : an equal shot at recovery. 2021 Feb. p. 1–22.
- Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, Jit M. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021;397:1023–34. doi:10.1016/S0140-6736(21)00306-8.
- Sah R, Shrestha S, Mehta R, Sah SK, Raaban AR, Dharma K, Rodriguez-Morales AJ. AZD1222 (Covishield) vaccination for COVID-19: experiences, challenges and solutions in Nepal. Travel Med Infect Dis. 2021;40:101989. doi:10.1016/j.tmaid.2021.101989.
- Vouking MZ, Mengue CMA, Yauba S, Edengue JM, Dicko M, Dicko HM, Wiysonge CS. Interventions to increase the distribution of vaccines in Sub-Saharan Africa: a scoping review. Pan Afr Med J. 2019;32.
- Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Mudatsir M. Acceptance of a COVID-19 vaccine in Southeast Asia: a cross-sectional study in Indonesia. Front Public Health. 2020;8.